| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.3M | +29.3% |
| Cost of Revenue | $16.3M | +24.6% |
| Gross Profit | $9.0M | +38.8% |
| R&D Expense | $107K | +20.2% |
| SG&A Expense | $10.6M | +25.6% |
| Operating Income | -$3.3M | +11.2% |
| Interest Expense | $31K | — |
| Pre-tax Income | -$3.4M | +76.5% |
| Net Income | -$3.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -11.1% |
| Accounts Receivable | $3.0M | -32.2% |
| Inventory | $38K | -53.1% |
| Current Assets | $7.7M | -18.7% |
| Total Assets | $20.7M | -0.2% |
| Current Liabilities | $5.1M | -5.3% |
| Long-term Debt | $875K | -37.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $244K | +109.6% |
| Capital Expenditures | $27K | — |
| Investing Cash Flow | -$1.2M | +84.8% |
| Financing Cash Flow | $634K | -85.7% |
| Free Cash Flow | $217K | — |
| +76.5% |
| EPS (Basic) | -$0.35 | +79.4% |
| EPS (Diluted) | -$0.35 | +79.4% |
| Total Liabilities |
| $8.2M |
| +14.1% |
| Stockholders' Equity | $12.5M | -7.8% |